A Discussion on the Role of Generics 

• As drugs come off patent, how can a pharmaceutical or biotech company deal with impending generic competition?
• How can we use emerging markets as an outlet for new profit? What are some other areas of growth?
• Life cycle management issues.
• Drug portfolio diversification- how can we avoid putting “all of our eggs in one basket”?

The Impact of Healthcare Reform on the Pharmaceutical and Biotech Industries 

• What is the role of the pharmaceutical industry in healthcare reform? What legislation should we be pushing for? What legislation should we aim to avoid? 
• How will a government run component of healthcare legislation affect pharmaceutical and biotech companies? Will prescription drug sales increase in conjunction with the creation of a government component?

Deal Making in the Pharmaceutical and Biotech Industries

• How will economic recovery play a role in pharmaceutical M&A? As the recession begins to subside, will we continue to see an uptick in deals? 
• Predictions on where deals will be found going forward.
• What deal structure is going to work given the changing regulatory landscape?

The Environment for New Drug Development 

• How can we get new and innovative drugs into the large pharmaceutical companies?
  Pipeline issues.
• Discovery process v. strategic alliances- the pros and cons of both methods of new drug integration.

Biologics Legislation

• What types of regulatory requirements make sense to ensure that innovation continues in biotech and new drugs reach pharmaceutical companies?
• What are the key issues surrounding this debate? 
• What regulation should we be pushing for and what should we avoid?

Last updated 2/15/2010